The identification of the regulatory protein ENL as essential to an aggressive form of leukaemia provides insight into transcriptional regulation and highlights potential avenues for therapy. See Letters p.265 & p.270
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Journal of Hematology & Oncology Open Access 24 March 2022
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Biondi, A., Cimino, G., Pieters, R. & Pui, C.-H. Blood 96, 24–33 (2000).
Erb, M. A. et al. Nature 543, 270–274 (2017).
Wan, L. et al. Nature 543, 265–269 (2017).
Li, Y. et al. Cell 159, 558–571 (2014).
Meyer, C. et al. Leukemia 20, 777–784 (2006).
Smith, E., Lin, C. & Shilatifard, A. Genes Dev. 25, 661–672 (2011).
Chen, C.-W. & Armstrong, S. A. Exp. Hematol. 43, 673–684 (2015).
He, N. et al. Proc. Natl Acad. Sci. USA 108, E636–E645 (2011).
Okada, Y. et al. Cell 121, 167–178 (2005).
Daigle, S. R. et al. Cancer Cell 20, 53–65 (2011).
Bernt, K. M. et al. Cancer Cell 20, 66–78 (2011).
Deshpande, A. J. et al. Cancer Cell 26, 896–908 (2014).
Chen, S. et al. Mol. Cell 60, 319–327 (2015).
Vlaming, H. & van Leeuwen, F. Chromosoma 125, 593–605 (2016).
Patel, D. J. & Wang, Z. Annu. Rev. Biochem. 82, 81–118 (2013).
Nicodeme, E. et al. Nature 468, 1119–1123 (2010).
Filippakopoulos, P. et al. Nature 468, 1067–1073 (2010).
Jang, M. K. et al. Mol. Cell 19, 523–534 (2005).
Li, Y. et al. Mol. Cell 62, 181–193 (2016).
O.G. is a co-founder of EpiCypher, Inc. and Athelas Therapeutics, Inc.
About this article
Cite this article
Wilkinson, A., Gozani, O. Reading the future of leukaemia. Nature 543, 186–187 (2017). https://doi.org/10.1038/nature21894
This article is cited by
Journal of Hematology & Oncology (2022)
Cellular and Molecular Life Sciences (2018)